PMS39 COST-EFFECTIVENESS OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS IN BRAZIL
May 1, 2020, 00:00
10.1016/j.jval.2020.04.725
https://www.valueinhealthjournal.com/article/S1098-3015(20)30913-X/fulltext
Title :
PMS39 COST-EFFECTIVENESS OF SECUKINUMAB IN THE TREATMENT OF ANKYLOSING SPONDYLITIS IN BRAZIL
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(20)30913-X&doi=10.1016/j.jval.2020.04.725
First page :
Section Title :
Open access? :
No
Section Order :
10625